PKM2 regulates Glil expression in hepatocellular carcinoma

被引:15
|
作者
Xu, Qiuran [1 ,2 ]
Liu, Xin [3 ]
Zheng, Xin [1 ]
Yao, Yingmin [1 ]
Liu, Qingguang [1 ]
机构
[1] Xi An Jiao Tong Univ, Dept Hepatobiliary Surg, Affiliated Hosp 1, Coll Med, Xian 710061, Shaanxi, Peoples R China
[2] Zhejiang Prov Peoples Hosp, Emergency Dept, Hangzhou 310014, Zhejiang, Peoples R China
[3] Xi An Jiao Tong Univ, Dept Neurosurg, Affiliated Hosp 1, Coll Med, Xian 710061, Shaanxi, Peoples R China
关键词
hepatocellular carcinoma; PKM2; Glil; PYRUVATE-KINASE M2; GENE-TRANSCRIPTION; DOWN-REGULATION; SONIC HEDGEHOG; CANCER; CELLS; PATHWAY; PROLIFERATION; ACTIVATION; MIGRATION;
D O I
10.3892/ol.2014.2441
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Hedgehog (Hh) signaling and the pyruvate kinase isoenzyme M2 (PKM2 or M2-PK) are often involved in tumorigenesis and growth. Aberrant activation of Hh signaling is found in a variety of malignancies. In tumor cells, PKM2 determines whether glucose is used for the synthesis of cellular building blocks or the production of lactate for energy regeneration; it associated with the Warburg effect. Glil is a downstream molecule of the Hh signaling pathway; however, the association between Hh signaling and PKM2 is not well understood. In the present study, it was identified that PKM2 and Glil expression levels were significantly elevated in hepatocellular carcinoma (HCC) compared with para-carcinoma. In vitro study revealed that overexpression of PKM2 in HepG2 cells upregulated the transcription of Glil, while the ablation of PKM2 by shRNA caused the downregulation of Glil gene expression. Glil transcription could be rescued by PKM2. Overall, these findings suggest that PKM2 is a regulator of Glil gene expression in HCC, and may contribute to tumorigenesis through Glil.
引用
收藏
页码:1973 / 1979
页数:7
相关论文
共 50 条
  • [1] PKM2 affects the development of hepatocellular carcinoma
    Zhao, Rui
    Li, Lei
    Yang, Jinbo
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2016, 9 (06): : 9744 - 9751
  • [2] High PKM2 expression is independently correlated with decreased overall survival in hepatocellular carcinoma
    Lu, Dong-Hui
    Lv, Wen-Wen
    Li, Wen-Xing
    Gao, Yue-Dong
    ONCOLOGY LETTERS, 2018, 16 (03) : 3603 - 3610
  • [3] Clinicopathological and prognostic significance of PKM2 protein expression in cirrhotic hepatocellular carcinoma and non-cirrhotic hepatocellular carcinoma
    Liu, Yan
    Wu, Hao
    Mei, Ying
    Ding, Xiong
    Yang, Xiaoli
    Li, Changping
    Deng, Mingming
    Gong, Jianping
    SCIENTIFIC REPORTS, 2017, 7
  • [4] Non-metabolic enzyme function of PKM2 in hepatocellular carcinoma: A review
    Zhang, Shuangxia
    Liao, Zhangxiu
    Li, Shubo
    Luo, Ying
    MEDICINE, 2023, 102 (42) : E35571
  • [5] PKM2 Drives Hepatocellular Carcinoma Progression by Inducing Immunosuppressive Microenvironment
    Li, Tian-En
    Wang, Shun
    Shen, Xiao-Tian
    Zhang, Ze
    Chen, Mo
    Wang, Hao
    Zhu, Ying
    Xu, Da
    Hu, Bei-Yuan
    Wei, Ran
    Zheng, Yan
    Dong, Qiong-Zhu
    Qin, Lun-Xiu
    FRONTIERS IN IMMUNOLOGY, 2020, 11
  • [6] PKM2 and cancer: The function of PKM2 beyond glycolysis
    Dong, Gaochao
    Mao, Qixing
    Xia, Wenjie
    Xu, Youtao
    Wang, Jie
    Xu, Lin
    Jiang, Feng
    ONCOLOGY LETTERS, 2016, 11 (03) : 1980 - 1986
  • [7] Germline loss of PKM2 promotes metabolic distress and hepatocellular carcinoma
    Dayton, Talya L.
    Gocheva, Vasilena
    Miller, Kathryn M.
    Israelsen, William J.
    Bhutkar, Arjun
    Clish, Clary B.
    Davidson, Shawn M.
    Luengo, Alba
    Bronson, Roderick T.
    Jacks, Tyler
    Vander Heiden, Matthew G.
    GENES & DEVELOPMENT, 2016, 30 (09) : 1020 - 1033
  • [8] Arsenic trioxide inhibits EMT in hepatocellular carcinoma by promoting lncRNA MEG3 via PKM2
    Fan, Zhuoyang
    He, Jing
    Fu, Tong
    Zhang, Wei
    Yang, Guowei
    Qu, Xudong
    Liu, Rong
    Lv, Lei
    Wang, Jianhua
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2019, 513 (04) : 834 - 840
  • [9] Nuclear PKM2 expression, an independent risk factor for ER after curative resection of hepatocellular carcinoma
    Fan, Fangtian
    Wu, Hongyan
    Liu, Zhaoguo
    Hou, Xianbang
    Chen, Wenxin
    Wang, Aiyun
    Lu, Yin
    BIOMEDICINE & PHARMACOTHERAPY, 2016, 84 : 1858 - 1864
  • [10] Co-expression of PKM2 and TRIM35 predicts survival and recurrence in hepatocellular carcinoma
    Chen, Zhiao
    Lu, Xinyuan
    Wang, Zhichao
    Jin, Guangzhi
    Wang, Qifeng
    Chen, Di
    Chen, Taoyang
    Li, Jinjun
    Fan, Jia
    Cong, Wenming
    Gao, Qiang
    He, Xianghuo
    ONCOTARGET, 2015, 6 (04) : 2539 - 2548